Investigation of Effective Factors on the Quality of Life of Patients Suffering from Ulcerative Colitis in Remission

Investigation of Effective Factors on the Quality of Life of Patients Suffering from Ulcerative Colitis in Remission

Authors Information

1 Department of Internal Medicine,Velayat Clinical Research Development Unit,Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran
2 Velayat Clinical Research Development Unit, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

Article Notes and Dates

Biotechnology and Health Sciences: May 2017, S(1); e41877.Published Online: November 13, 2016
Article Type: Research Article; Received: August 29, 2016; Accepted: October 26, 2016
DOI: http://dx.doi.org/10.5812/bhs-41877
To Cite : Hajaghamohammadi A A, Keshavarzi B, Zargar A. Investigation of Effective Factors on the Quality of Life of Patients Suffering from Ulcerative Colitis in Remission, Biotech Health Sci. 2017 ;S(1):e41877. doi: 10.5812/bhs-41877.
Copyright: Copyright © 2017, Biotechnology and Health Sciences. .
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, et al. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis. 2012; 18(8): 1540-9[PubMed]
  • 2. da Silva BC, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014; 20(28): 9458-67[PubMed]
  • 3. Cohen D, Bin CM, Fayh AP. Assessment of quality of life of patients with inflammatory bowel disease residing in Southern Brazil. Arq Gastroenterol. 2010; 47(3): 285-9[PubMed]
  • 4. Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007; 1(1): 10-20[PubMed]
  • 5. Safarpour AR, Hosseini SV, Mehrabani D. Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review. Iran J Med Sci. 2013; 38(2 Suppl): 140-9[PubMed]
  • 6. Kozlowska KA, Baczyk G, Krokowicz P. Quality of life in patients with ulcerative colitis treated surgically. Prz Gastroenterol. 2014; 9(4): 220-6[PubMed]
  • 7. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health. 2006; 2: 24[PubMed]
  • 8. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 2005; 11(10): 909-18[PubMed]
  • 9. Tabibian A, Tabibian JH, Beckman LJ, Raffals LL, Papadakis KA, Kane SV. Predictors of health-related quality of life and adherence in Crohn’s disease and ulcerative colitis: implications for clinical management. Dig Dis Sci. 2015; 60(5): 1366-74[PubMed]
  • 10. Huppertz-Hauss G, Lie Hoivik M, Jelsness-Jorgensen LP, Henriksen M, Hoie O, Jahnsen J, et al. Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study. Inflamm Bowel Dis. 2016; 22(7): 1679-87[PubMed]
  • 11. Reinisch W, Sandborn WJ, Bala M, Yan S, Feagan BG, Rutgeerts P, et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis. 2007; 13(9): 1135-40[PubMed]
  • 12. Bannaga AS, Selinger CP. Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol. 2015; 8: 111-7[PubMed]
  • 13. Van de star T. “Role of Psychosocial Factors on the Course of Inflammatory Bowel Disease and Associated Psychotherapeutic Approaches. A Fresh Perspective and Review”. Gastroenterology and Hepatology : Open Access. 2015; 2(2)[DOI]
  • 14. Bernklev T, Jahnsen J, Schulz T, Sauar J, Lygren I, Henriksen M, et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol. 2005; 17(10): 1037-45[PubMed]
  • 15. Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010; 16(12): 2137-47[PubMed]
  • 16. Maleki I, Taghvaei T, Barzin M, Amin K, Khalilian A. Validation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients. Caspian J Intern Med. 2015; 6(1): 20-4[PubMed]
  • 17. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005; 14(3): 875-82[PubMed]
  • 18. de Boer AG, Wijker W, Bartelsman JF, de Haes HC. Inflammatory Bowel Disease Questionnaire: cross-cultural adaptation and further validation. Eur J Gastroenterol Hepatol. 1995; 7(11): 1043-50[PubMed]
  • 19. Han SW, McColl E, Barton JR, James P, Steen IN, Welfare MR. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis. 2005; 11(1): 24-34[PubMed]
  • 20. Walewska E, Scisło, L. , Kózka, M. . Quality of life in patients suffering from colitis ulcerosa [Polish]. Annales Universitatis Mariae Curie-Skłodowska Lublin. 2005; : 147-51
  • 21. Bączyk G, Karoń J, Krokowicz P. The objective and subjective dimension of quality of life in patients with inflammatory bowel diseases treated on surgical wards. Gastroenterology Review. 2011; 3: 170-5[DOI]
  • 22. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol. 2001; 13(5): 567-72[PubMed]
  • 23. Kalafateli M, Triantos C, Theocharis G, Giannakopoulou D, Koutroumpakis E, Chronis A, et al. Health-related quality of life in patients with inflammatory bowel disease: a single-center experience. Ann Gastroenterol. 2013; 26(3): 243-8[PubMed]
  • 24. Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn’s disease and intestinal Behcet’s disease. Int J Colorectal Dis. 1999; 14(1): 52-7[PubMed]
  • 25. Pallis AG, Vlachonikolis IG, Mouzas IA. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire. Digestion. 2001; 63(4): 240-6[PubMed]
  • 26. Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005; 21(5): 499-508[PubMed]
  • 27. Haapamaki J, Turunen U, Roine RP, Farkkila MA, Arkkila PE. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res. 2009; 18(8): 961-9[PubMed]